The Journal of Allergy and Clinical Immunology
Volume 124, Issue 6 , Pages 1259-1266, December 2009

Hypersensitivity reactions to mAbs: 105 desensitizations in 23 patients, from evaluation to treatment

Received 13 July 2009; received in revised form 3 September 2009; accepted 8 September 2009. published online 12 November 2009.

Full Text Available

  • Purchase this article for  31.50 USD

    Access is available for 24 hours.

    (Login or Register to purchase)

  • Subscribe to this title
  • Claim access now

    Current subscribers


    •  The desensitization program at Dana Farber Cancer Institute and Brigham and Women's hospital is supported in part by Ovations for the Cure.

     Disclosure of potential conflict of interest: P. J. Brennan received research support from the National Institutes of Health. T Rodriguez Bouza received research support from Real Colegio Complutense. F. I. Hsu received research support from Dyax. D. E. Sloane previously served on the speakers' bureau for Genentech and Novartis. M. C. Castells served as a consultant for Schering-Plough and ICON, received research support from Ovations for the Cure, and served as an expert witness on adverse drug reactions and desensitizations.

    PII: S0091-6749(09)01338-4

    doi:10.1016/j.jaci.2009.09.009

    The Journal of Allergy and Clinical Immunology
    Volume 124, Issue 6 , Pages 1259-1266, December 2009